Medication info
Metin M Tablet 10 mg (Memantine Hydrochloride)

Metin M Tablet 10 mg (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Mothers Pharmaceutical Co., Ltd.
Appearance
White oblong film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202003049 · Approved 2020.04.27

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
Administer this medicine orally once daily at the same time each day. If necessary, it may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows, until the maintenance dose is reached. First week (Day 1~7) Administer 5mg daily for 7 days. Second week (Day 8~14) Administer 10mg daily for 7 days. Third week (Day 15~21) Administer 15mg daily for 7 days. From the fourth week onward Administer 20mg daily. Maintenance dose: The recommended maintenance dose is 20mg daily. 2. Elderly patients: Based on clinical data, the recommended dose for elderly patients aged 65 years and older is 20mg daily. 3. Patients with renal impairment: No dosage adjustment is necessary for patients with mild renal impairment (creatinine clearance: 50-80 mL/min). For patients with moderate renal impairment (creatinine clearance 30-49 mL/min), reduce the daily dose to 10mg. If well tolerated for at least 7 days after administration, the dose may be increased to 20mg daily according to the standard dose-escalation schedule. For patients with severe renal impairment (creatinine clearance 5-29 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment: No dosage adjustment is necessary for patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Ingredients

Manufacturer
Mothers Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used for patients with moderate to severe Alzheimer's disease. It helps improve memory and cognitive function, thereby assisting patients in conducting their daily lives more smoothly. It is effective in slowing the progression of symptoms or managing those symptoms. As a result, it contributes to improving the quality of life for both patients and their families. For these reasons, it is used to treat moderate to severe Alzheimer's disease.

How to take

Adult dose

Administer this medicine orally once daily at the same time each day. If necessary, it may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows, until the maintenance dose is reached. First week (Day 1~7) Administer 5mg daily for 7 days. Second week (Day 8~14) Administer 10mg daily for 7 days. Third week (Day 15~21) Administer 15mg daily for 7 days. From the fourth week onward Administer 20mg daily. Maintenance dose: The recommended maintenance dose is 20mg daily. 2. Elderly patients: Based on clinical data, the recommended dose for elderly patients aged 65 years and older is 20mg daily. 3. Patients with renal impairment: No dosage adjustment is necessary for patients with mild renal impairment (creatinine clearance: 50-80 mL/min). For patients with moderate renal impairment (creatinine clearance 30-49 mL/min), reduce the daily dose to 10mg. If well tolerated for at least 7 days after administration, the dose may be increased to 20mg daily according to the standard dose-escalation schedule. For patients with severe renal impairment (creatinine clearance 5-29 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment: No dosage adjustment is necessary for patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Precautions

This drug should not be used in patients with hypersensitivity to its ingredients or severe liver or kidney dysfunction. Caution is required for patients with epilepsy or those who have experienced seizures in the past, as the risk of side effects may increase when taking certain NMDA antagonist drugs together. Patients with elevated urinary pH should also be carefully monitored, and there is insufficient clinical data available for patients with heart disease or uncontrolled hypertension, so caution is advised. When taking this medication, side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur, and additionally, central nervous system symptoms such as confusion, hallucinations, and seizures may appear. Moreover, this drug can interact with several other medications, so it is important to consult a doctor or pharmacist when taking it with NMDA antagonists, antipsychotics, antihypertensives, anticoagulants, etc. Women who are pregnant or may become pregnant should carefully consider the risks and benefits before taking this medication, and nursing mothers are advised to discontinue breastfeeding. It is preferable not to use this drug in children or adolescents under 18 years of age, as safety and efficacy have not been established. In the case of overdose, central nervous system symptoms or gastrointestinal symptoms may appear, and immediate medical attention is required. This medication could affect a patient's response time and concentration, so caution is needed when driving or operating machinery. Finally, this medication should be kept out of the reach of children and should not be transferred to another container for safety.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug sensitivity reaction
  • drowsiness
  • confusion
  • hallucination
Show 36 more
  • psychotic reaction
  • dizziness
  • balance disorder
  • gait abnormality
  • seizure
  • heart failure
  • hypertension
  • venous thrombosis/thromboembolism
  • shortness of breath
  • constipation
  • vomiting
  • pancreatitis
  • elevated liver enzyme levels
  • hepatitis
  • headache
  • fatigue
  • tiredness
  • weakness
  • diarrhea
  • confusion
  • drowsiness
  • drowsiness
  • dizziness
  • agitation
  • aggression
  • hallucination
  • gait disturbance
  • vomiting
  • diarrhea
  • restlessness
  • psychosis
  • visual hallucination
  • convulsion
  • drowsiness
  • confusion
  • unconsciousness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering and should preferably be kept at room temperature between 1°C and 30°C. By storing it this way, the medication's efficacy can be maintained, and degradation can be prevented.

Appearance and packaging

Appearance

White oblong film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.